Notably, several of these enzymes are druggable: for example, PLOD1 and PLOD2, which are involved in collagen crosslinking, can be targeted by specific inhibitors such as minoxidil, which disrupts collagen maturation and tumor-stroma interactions [65]. This evidence concerns the gene PLOD2 and neoplasm.